News

Owlstone Medical closes $7M (£4.9M) investment to commercialize disease breathalyzer

Owlstone Inc. Announces Phase III Award under Its Next Generation Chemical Detector (NGCD) Contract for the US DOD’s JPEO-CBD

Lung cancer breathalyzer in UK clinical trials

Owlstone Medical wins Life Science Innovation award

Owlstone Medical wins NHS contract for STRATA

Owlstone Inc., in Partnership with UTC Aerospace Systems, Awarded the Only Department of Homeland Security Contract to Develop a New Handheld Explosives Detector

Owlstone Inc. Awarded Next Generation Chemical Detector (NGCD) Prototype Phase II for the US DOD’s JPEO-CBD

BBC World News - Horizons

New publication: The application of FAIMS gas analysis in medical diagnostics

High Hopes for Cancer Breathalyzer

LuCID success to inspire future engineers at Cambridge University

BBC News - LuCID clinical trial